To confirm that Cdc42‐GTPase could promote migration and invasion in BRAFi‐R melanoma cells, we exposed HTB63‐R cells to a specific‐Cdc42‐GTPase inhibitor, for example ML141 (Surviladze et al., 2010). The gene discussed is CDC42; the disease is melanoma.